Letter: Treatment of malignant haemopathies and ur...[Lancet. 1975] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Lancet. 1975 Jan 25;1(7900):229.Links

Letter: Treatment of malignant haemopathies and urate oxidase.

Kissel P, Mauuary G, Royer R, Toussain P.

PMID: 47468 [PubMed - indexed for MEDLINE]

Related articles

[Letter: Hyperuricemia in hematological pathology. Therapy and prevention using urate oxidase]
Nouv Presse Med. 1974 Sep 28; 3(32):2026.

[Nouv Presse Med. 1974]
A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis.
Blood. 2001 May 15; 97(10):2998-3003.

[Blood. 2001]
[Urate-oxidase: a new therapy of cytotoxic-drug-induced hyperuricemia (author's transl)]
Haematologica. 1981 Oct; 66(5):656-66.

[Haematologica. 1981]
Review[Current treatment of hyperuricemia]
Sem Hop Ther. 1977 May-Jun; 53(5-6):321-8.

[Sem Hop Ther. 1977]
ReviewSerum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase.
Curr Rheumatol Rep. 2004 Jun; 6(3):240-7.

[Curr Rheumatol Rep. 2004]
» See reviews... | » See all...

Patient Drug Information

Allopurinol (Aloprim® , Zyloprim® )
Allopurinol is used to treat gout, high levels of uric acid in the body caused by certain cancer medications, and kidney stones. Allopurinol is in a class of medications called xanthine oxidase inhibitors. It works by re...
Source: AHFS Consumer Medication Information

Recent Activity

Clear Turn Off Turn On

Letter: Treatment of malignant haemopathies and urate oxidase.Letter: Treatment of malignant haemopathies and urate oxidase.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show